Pre-Exposure Prophylaxis (PrEP) is the highly effective use of antiretrovial medications by people without HIV to protect themselves from getting HIV. The U.S. Food and Drug Administration approved the first PrEP for HIV prevention in 2012. Today, PrEP can be taken in the form of pills or shots. CDC estimates that 1.2 million people could benefit from PrEP in the United States. However, there is a significant gap in the literature and practice guidelines regarding anesthesia considerations for patients utilizing PrEP medications.

This presentation will address the anesthesia providers gap in knowledge regarding this important HIV prevention tool. The content of this lecture will include 3 major topics:

1. The current state of HIV and HIV Prevention in the US, including the high risk populations and barriers totreatment
2. An introduction to Pre-exposure Prophylaxis (PrEP) including the indications and types of PrEP
3. An overview of theImplications for anesthesia providers including medication interactions, effects of the PrEP on the body, and anesthetic implications of PrEPmedications.

Learning Outcome(s):

1. Learners will describe the current state of HIV and HIV prevention in the US.
2. Learners will be able to describe pre-exposure prophylaxis (PrEP) including the indications, dosage, and route.
3. Learners will be able to discuss the implications for anesthesia providers including medication interactions, effects of the PrEP on the body, and anesthetic implications.

This program has been prior approved by the American Association of Nurse Anesthesiology for 1.0 Class A CE credits; Code Number 1044800; Expiration Date 2/20/2025. AANA designates this program as meeting the criteria for up to 1.0 CE Credits in pharmacology/therapeutics. 

Jennifer Ross Majumdar, PhD, CRNA (she/her/hers)

Accreditation Information:
The American Association of Nurse Anesthesiology is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. 

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Disclosure Statement:
Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Post-Test Attempt Notice:
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:
The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthesiology.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthesiology has no responsibility or liability for the accuracy or completeness of the content.

Refund Policy:
Continuing education activities are nonrefundable.